ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag serine threonine kinase culture disease medicine

An automated sampler that is collecting a sample from a sewer line.
Tracking Community Health Through Wastewater Surveillance
Charlene Lancaster, PhD | Feb 1, 2024 | 8 min read
By monitoring disease biomarkers within wastewater, researchers gain insight into disease prevalence within communities.
Phospho-Mania
Aileen Constans | Nov 7, 2004 | 6 min read
ERK1/2 ACTIVATIONCourtesy of Biosource Internationalis plainly visible in heart tissue from an MHC-Rac1 transgenic mouse (right), compared with its normal counterpart (left). Green, pERK 1/2 (pTEpY185/187); blue, actin; red, nuclei.Protein phosphorylation is one of the most widely studied posttranslational modifications, with good reason. Many cellular signaling events rely on the addition or subtraction of phosphate groups (by kinases and phosphatases, respectively) to serine, threonine, and ty
A rendering of a human brain in blue on a dark background with blue and white lines surrounding the brain to represent the construction of new connections in the brain.
Defying Dogma: Decentralized Translation in Neurons
Danielle Gerhard, PhD | Sep 8, 2023 | 10+ min read
To understand how memories are formed and maintained, neuroscientists travel far beyond the cell body in search of answers.
a false color transmission electron microscope image of a neuronal cell body, with lysosomes colored dark green
Scientists Uncover Major Pathway Cells Use to Mend Leaky Lysosomes
Holly Barker, PhD | Oct 6, 2022 | 3 min read
Damaged lysosomes are repaired by a lipid-based signaling pathway dubbed PITT that could be targeted to treat neurodegenerative disease, its discoverers say.
A Phosphorylation Pioneer
Karen Hopkin | Apr 1, 2006 | 6 min read
Tony Hunter discovered tyrosine kinases because he was lazy - then the fun began
Biochemistry's Fab Five
Philip Cohen | Jan 18, 2004 | 3 min read
Glycolysis revision, kinases, and the first "second messenger" star in these five favorite papers
Keeping innate immunity at bay
Michaela Torkar(michaelatorkar@hotmail.com) | Jul 30, 2002 | 1 min read
The mammalian kinase IRAK-M is a negative regulator of Toll-like receptor signaling and controls potentially harmful inflammatory immune reactions.
The Proteasome: A Powerful Target for Manipulating Protein Levels
John Hines and Craig M. Crews | May 1, 2017 | 10+ min read
The proteasome’s ability to target and degrade specific proteins is proving useful to researchers studying protein function or developing treatments for diseases.
My Mighty Mouse
Megan Scudellari | Apr 1, 2015 | 10+ min read
Personal drug regimens based on xenograft mice harboring a single patient’s tumor still need to prove their true utility in medicine.
Cancer
The Scientist Staff | Mar 28, 1999 | 6 min read
J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S.I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S.H. Bigner, B.C. Giovanella, M. Ittman, B. Tycko, H. Hibshoosh, M.W. Wigler, R. Parsons, "PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer," Science, 275:1943-7, 1997. (Cited in more than 270 papers since publication) Peter A. Steck Comments by Ramon Parsons , professor of pathology and medicine, Columbia University Cancer Center,

Run a Search

ADVERTISEMENT